Kamath: Similar to the phase 3 HERIZON-GEA-01 trial, what’s really the overall theme of these is that we have to identify ...

This years 2026 ASCO Gastrointestinal Cancers Symposium was packed with practice-shaping data across colorectal and upper ...

Discover how antibody-drug conjugates (ADCs) are transforming treatment strategies for gastrointestinal cancers, enhancing ...

NEW YORK, Jan. 28, 2026 /PRNewswire/ -- NYU Langone Health announced the appointment of Anirban Maitra, MD, a pre-eminent physician--scientist whose work has widely influenced the field of pancreatic ...

A study at two US medical centers found that patients with brain metastases from gastrointestinal (GI) cancers had significantly worse overall survival and intracranial progression-free survival (PFS) ...

Adults with pSS may face significantly increased risks for certain GI cancers, specifically colorectal and pancreatic cancers.

The global oncology sector is rocketing toward $668 billion in 2034[1], partly fueled by a massive structural pivot toward gastrointestinal ...

Treatment for upper gastrointestinal (GI) cancers depends on several factors, including the type, location, and stage of the cancer (how far it has advanced). Treatments may include surgery, ...

Tiago Biachi, MD, PhD, highlighted the transformative role of personalized medicine in gastrointestinal (GI) cancer treatment through advances in next-generation sequencing and circulating tumor DNA, ...

Editor’s note: The “Research Spotlight” series is written by Dr. Anna Berkenblit, PanCAN’s Chief Scientific and Medical ...

A recent study has identified a potential new tool to help detect gastrointestinal cancers — the platelet-to-high-density lipoprotein ratio, or PHR. Researchers analyzed data from more than 19,000 ...

The American Cancer Society’s annual cancer trends report revealed a mix of news and statistics for 2025. Cancer death rates have dropped 34% between 1991 and 2022, which the ACS attributes to early ...